Neuromyelitis Optica Spectrum Disorder Market to grow by USD 173.48 million from 2022 to 2027

The global neuromyelitis optica spectrum disorder market is projected to grow at a CAGR of 6.16% from 2022 to 2027, driven by the growing geriatric population and increasing demand for neuromyelitis optica spectrum disorder drugs.

yahoo.com

Relevant topic timeline:

8/24/2023

Ophthalmic Disease Therapeutics Market Set to Soar Past USD 53.8 Billion by 2030

The global Ophthalmic Disease Therapeutics Market is projected to reach USD 53.8 billion by 2030, with a CAGR of 6.10% in the forecast period, driven by factors such as the increasing prevalence of ophthalmic diseases and advancements in treatment options.

9/3/2023

The Dermatology Market to grow by USD 12.762 billion from 2022 to 2027

The global dermatology market is projected to grow by USD 12.76 billion from 2022 to 2027, with a CAGR of 10.82%, driven by the increasing prevalence of teledermatology and the growing demand for telemedicine, making dermatology care more accessible.

9/11/2023

Neuroscience Antibodies and Assays Market to Grow Nearly $2 Billion by 2027, Driven by Neurological Disorders and Aging Population

The global neuroscience antibodies and assays market is projected to grow by USD 1.83 billion from 2022 to 2027, with North America contributing significantly to the market's growth due to the rising need for diagnosing neurological disorders.

9/13/2023

Global Clinical Nutrition Products Market Size Grows Steadily, Driven by Major Players Like Bausch & Lomb and Regional Demand

The global Clinical Nutrition Products Market is expected to experience significant growth by 2031, with an estimated CAGR that will reach USD million.